UBS News


UBS AG schliesst Bezugsrechts-Kapitalerhöhung erfolgreich ab

Zürich / Basel | | Price Sensitive Information

Die UBS AG schliesst die von den Aktionären anlässlich der ordentlichen Generalversammlung vom 23. April 2008 genehmigte Bezugsrechtskapitalerhöhung im Umfang von CHF 15,97 Mrd. erfolgreich ab.

Im Rahmen der ordentlichen Kapitalerhöhung hat die UBS AG 760'295'181 neue Aktien mit einem Nennwert von CHF 0,10 je Aktie ausgegeben. Der Bezugspreis der neuen Aktien war bei CHF 21,00 festgelegt worden. Gültig ausgeübt wurden Bezugsrechte zur Zeichnung von 755'466'901 neuen Aktien, was einem Anteil von 99,4% aller zur Zeichnung angebotenen neuen Aktien entspricht. 4'828'280 neue Aktien, für welche Bezugsrechte nicht gültig ausgeübt wurden, werden am 13. Juni 2008 durch UBS Investment Bank über den Markt verkauft.

Der Handel in den neuen Aktien an der SWX Europe, der New York Stock Exchange und der Tokyo Stock Exchange wird voraussichtlich heute beginnen. Zahlung und Lieferung der neuen Aktien erfolgen voraussichtlich am 17. Juni 2008.

Notice to Shareholders in Switzerland and the European Economic Area
This publication constitutes neither an offer to sell nor a solicitation to buy securities of UBS AG. It does not constitute an offering prospectus within the meaning of Art. 652a of the Swiss Code of Obligations, nor a listing prospectus within the meaning of the SWX Swiss Exchange Listing Rules. The offer is being made solely by means of, and on the basis of, the published offering and listing prospectus dated May 23, 2008 (including any amendments thereto, if any). An investment decision regarding the publicly offered securities of UBS AG should only be made on the basis of this offering and listing prospectus. The offering and listing prospectus is available free of charge from UBS Investment Bank, Prospectus Library, P.O. Box, CH-8098 Zurich, Switzerland, J.P. Morgan Securities Ltd., Junghofstr. 14, 60313 Frankfurt am Main, Germany or Morgan Stanley Bank AG, Junghofstrasse 13-15, 60311 Frankfurt am Main, Germany or on UBS AG's website (www.ubs.com).

Other than in Germany, Austria, the United Kingdom, France, Italy and Liechtenstein, no action has been or will be taken in any member state of the European Economic Area which has implemented the EC Directive 2003/71/EC of the European Parliament Council dated November 4, 2003 (each a "Relevant Member State") that would permit a public offering of the new shares, or the distribution of a prospectus or any other offering material relating to the new shares in any Relevant Member State.

Notice to U.S. Persons
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the "SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling UBS AG at +41-44-236-6770 or, if you are calling from the United States of America, by calling toll-free +1-866-541-9689.